Mill Creek Capital Advisors’s Precigen PGEN Stock Holding History

Mill Creek Capital Advisors’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$581K	Buy	150,150 +150	+0.1%	+$615	0.01%	150
2025 Q4	$627K	Hold	150,000	–	–	0.01%	147
2025 Q3	$494K	Sell	150,000 -105,000	-41%	-$296K	0.01%	167
2025 Q2	$362K	Hold	255,000	–	–	0.01%	193
2025 Q1	$380K	Buy	255,000 +145,000	+132%	+$228K	0.01%	182
2024 Q4	$123K	Hold	110,000	–	–	﹤0.01%	257
2024 Q3	$104K	Buy	+110,000	New	+$139K	﹤0.01%	248

Other funds holding PGEN

PCM

Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

OCM

Occam Crest Management Darien, Connecticut $193M AUM 233.09% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Mill Creek Capital Advisors's PGEN Position: Q1 2026 in Review

Mill Creek Capital Advisors increased its Precigen (PGEN) stake by 0.1% in Q1 2026, buying an estimated $615 and bringing the position to 150,150 shares worth $581K. The position accounts for 0.01% of the portfolio, ranked #150.

Mill Creek Capital Advisors first reported a position in PGEN in Q3 2024 and has held it in 7 quarters since. The position peaked at $627K in Q4 2025. 206 funds tracked by Wall St. Rank hold PGEN as of Q1 2026.

Mill Creek Capital Advisors held 150,150 shares of Precigen worth $581K as of Q1 2026.
Mill Creek Capital Advisors bought 150 Precigen shares in Q1 2026, an estimated $615.
Precigen made up 0.01% of Mill Creek Capital Advisors's portfolio in Q1 2026, its #150 holding.
Mill Creek Capital Advisors first reported a position in Precigen in Q3 2024 and has held it in 7 quarters since.
Mill Creek Capital Advisors's Precigen position peaked at $627K in Q4 2025.
206 funds tracked by Wall St. Rank held Precigen as of Q1 2026.

Based on Mill Creek Capital Advisors's 13F filing for Q1 2026, filed 14 May 2026.